Canopy Growth (NASDAQ:CGC) versus ONE Bio (OTCMKTS:ONBI) Financial Contrast

Canopy Growth (NASDAQ:CGCGet Rating) and ONE Bio (OTCMKTS:ONBIGet Rating) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, valuation, profitability, risk, dividends, earnings and institutional ownership.

Institutional and Insider Ownership

15.8% of Canopy Growth shares are owned by institutional investors. 0.2% of Canopy Growth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Risk and Volatility

Canopy Growth has a beta of 1.99, suggesting that its stock price is 99% more volatile than the S&P 500. Comparatively, ONE Bio has a beta of -5.56, suggesting that its stock price is 656% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and price targets for Canopy Growth and ONE Bio, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Canopy Growth 6 5 2 0 1.69
ONE Bio 0 0 0 0 N/A

Canopy Growth presently has a consensus target price of $5.28, indicating a potential upside of 102.36%. Given Canopy Growth’s higher possible upside, analysts plainly believe Canopy Growth is more favorable than ONE Bio.


This table compares Canopy Growth and ONE Bio’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Canopy Growth -621.80% -30.28% -17.73%

Valuation & Earnings

This table compares Canopy Growth and ONE Bio’s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Canopy Growth $415.09 million 3.11 -$241.08 million ($5.83) -0.45

ONE Bio has lower revenue, but higher earnings than Canopy Growth.


Canopy Growth beats ONE Bio on 6 of the 9 factors compared between the two stocks.

About Canopy Growth

(Get Rating)

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

About ONE Bio

(Get Rating)

One Bio Corp. engages in the utilization of green processes to produce raw chemicals and herbal extracts, natural supplements, and organic products. The company was founded on June 30, 2000 and is headquartered in Aventura, FL.

Receive News & Ratings for Canopy Growth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Canopy Growth and related companies with's FREE daily email newsletter.